Mosteiro Alejandra, Pedrosa Leire, Codes Marta, Reyes Luís, Werner Mariano, Amaro Sergio, Enseñat Joaquim, Rodríguez-Hernández Ana, Aalbers Marlien, Boogaarts Jeroen, Torné Ramon
Department of Neurosurgery, Hospital Clinic of Barcelona, University of Barcelona, Barcelona, Spain.
IDIBAPS Biomedical Research Institute, Barcelona, Spain.
Brain Spine. 2024 May 23;4:102838. doi: 10.1016/j.bas.2024.102838. eCollection 2024.
Large and Giant intracranial aneurysms (LGIAs) have become the paradigm for which endovascular techniques do not provide satisfactory results. Yet, microsurgery is followed by non-negligible rates of morbimortality. This scenario may have changed since the introduction of flow-diversion devices.
Contemporary and standardised revision on microsurgical and endovascular results, with emphasis on anterior circulation LGIAs.
A systematic literature search was conducted in two databases (PubMed and Embase) on treatment outcomes of LGIAs of the anterior circulation, after the introduction of flow-diverters 2008/01/01, till 2023/05/20. Small case series (<5 cases), series including >15% of posterior circulation aneurysms, and studies not reporting clinical and/or angiographic outcomes were excluded.
44 relevant studies (observational cohorts) were identified, including 2923 LGIAs predominantly from anterior circulation. Mean follow-up 22 (±20) months. 1494 (51%) LGIAs were treated endovascularly and 1427 (49%) microsurgically. According to the random effects model, pooled rates of favourable clinical outcomes were 85.8% (CI 95% 82.6-88.4), complete occlusion 69.4% (CI 95% 63.7-7.46), complications 19.6% (CI 95%16-23.9) and mortality 5.6% (CI 95% 4.4-7.1). Focusing on type of treatment, occlusion rates are higher with microsurgical (842/993, 85% vs 874/1,299, 67%), although good outcomes are slightly more frequent with endovascular (1045/1,135, 92% vs 1120/1,294, 87%).
According to contemporary data about occlusion rates, functional outcomes, and complications, primary or secondary treatment of LGIAs of the anterior circulation seems justified. Microsurgical occlusion rates are higher in LGIAs. An expert consensus on reporting complications and management strategies is warranted.
大型和巨大型颅内动脉瘤(LGIA)已成为血管内治疗技术无法提供满意结果的范例。然而,显微手术的病残死亡率也不容小觑。自血流导向装置问世以来,这种情况可能已经有所改变。
对显微手术和血管内治疗结果进行当代标准化修订,重点关注前循环LGIA。
在两个数据库(PubMed和Embase)中进行系统文献检索,检索2008年1月1日至2023年5月20日引入血流导向装置后前循环LGIA的治疗结果。排除小病例系列(<5例)、后循环动脉瘤比例>15%的系列以及未报告临床和/或血管造影结果的研究。
确定了44项相关研究(观察性队列),包括2923例主要来自前循环的LGIA。平均随访22(±20)个月。1494例(51%)LGIA接受血管内治疗,1427例(49%)接受显微手术治疗。根据随机效应模型,良好临床结果的合并率为85.8%(95%CI 82.6 - 88.4),完全闭塞率为69.4%(95%CI 63.7 - 74.6),并发症发生率为19.6%(95%CI 16 - 23.9),死亡率为5.6%(95%CI 4.4 - 7.1)。聚焦于治疗类型,显微手术的闭塞率更高(842/993,85% 对比 874/1299,67%),尽管血管内治疗的良好结果略更常见(1045/1135,92% 对比 1120/1294,87%)。
根据关于闭塞率、功能结果和并发症的当代数据,前循环LGIA的一期或二期治疗似乎是合理的。LGIA中显微手术的闭塞率更高。有必要就并发症报告和管理策略达成专家共识。